Michael Seggev

Michael Seggev has 30+ years of commercial experience in digital health and biopharma. At Merck he led the commercial team that launched the company’s first-in-class medication to treat HIV/AIDS, altering the epidemic and achieving $1.8 B in peak annual sales. He then worked in Teva Pharmaceuticals’ Digital Health group developing and launching the first fully integrated drug/device/app combination, Teva’s connected Digihaler portfolio of inhalers for asthma and COPD.

After serving as Chief Commercial Officer at the AI Healthtech vocal biomarker startup Vocalis Health, Michael currently leads commercial at Donisi Health, a MedTech company providing in-home medical-grade monitoring of multiple cardiopulmonary parameters for patients with congestive heart failure (CHF) and other chronic diseases.